Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
IRF4 expression by lung dendritic cells drives acute but not Trm cell–dependent memory Th2 responses
Daniel F. Camacho, … , James J. Moon, Anne I. Sperling
Daniel F. Camacho, … , James J. Moon, Anne I. Sperling
Published October 4, 2022
Citation Information: JCI Insight. 2022;7(21):e140384. https://doi.org/10.1172/jci.insight.140384.
View: Text | PDF
Research Article Immunology

IRF4 expression by lung dendritic cells drives acute but not Trm cell–dependent memory Th2 responses

  • Text
  • PDF
Abstract

Expression of the transcription factor interferon regulatory factor 4 (IRF4) is required for the development of lung conventional DCs type 2 (cDC2s) that elicit Th2 responses, yet how IRF4 functions in lung cDC2s throughout the acute and memory allergic response is not clear. Here, we used a mouse model that loses IRF4 expression after lung cDC2 development to demonstrate that mice with IRF4-deficient DCs display impaired memory responses to allergen. This defect in the memory response was a direct result of ineffective Th2 induction and impaired recruitment of activated effector T cells to the lung after sensitization. IRF4-deficient DCs demonstrated defects in their migration to the draining lymph node and in T cell priming. Finally, T cells primed by IRF4-competent DCs mediated potent memory responses independently of IRF4-expressing DCs, demonstrating that IRF4-expressing DCs are not necessary during the memory response. Thus, IRF4 controlled a program in mature DCs governing Th2 priming and effector responses, but IRF4-expressing DCs were dispensable during tissue-resident memory T cell–dependent memory responses.

Authors

Daniel F. Camacho, Tania E. Velez, Maile K. Hollinger, Esther Wang, Chanie L. Howard, Eli P. Darnell, Domenick E. Kennedy, Paulette A. Krishack, Cara L. Hrusch, Marcus R. Clark, James J. Moon, Anne I. Sperling

×

Figure 1

IRF4-expressing DCs regulate the Trm cell–restricted type 2 inflammatory memory response to HDM rechallenges.

Options: View larger image (or click on image) Download as PowerPoint
IRF4-expressing DCs regulate the Trm cell–restricted type 2 inflammatory...
(A) Schematic of the experimental protocol for Trm cell–restricted memory response to HDM. (B) Total cellularity, eosinophils, CD4+ T cells, and CD8+ T cells in the airways (top) or lungs (bottom); n = 20. (C) H&E staining of the lungs confirms that mice with IRF4-deficient DCs are protected from allergic airway inflammation during the memory recall response to HDM; n = 20. Scale bar: 100 μm. (D) Number of CD24+ cDC2s and CD24– cDC2s in the lungs; n = 63. (E) For lung CD24+ cDC2s and CD24– cDC2s, MFI of CD86 normalized to the mean of the PBS-treated Irf4fl/fl group, with representative flow plots; n = 40. Data are (B and C) representative of or (D and E) combined from 3 independent experiments with n ≥ 4 mice per group in each experiment; statistics (B, ordinary 1-way ANOVA with Tukey’s multiple comparisons test; C and D, Mann-Whitney test) were performed in GraphPad Prism. Data are shown as the mean ± SEM (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Also see Supplemental Figures 2 and 4.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts